5 Health Services Stocks Dragging The Industry Down

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 56 points (-0.3%) at 15,939 as of Wednesday, Feb. 12, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,598 issues advancing vs. 1,323 declining with 154 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is down 0.1%. A company within the industry that fell today was Mettler-Toledo International ( MTD), up 1.4%. Top gainers within the industry include Mine Safety Appliances ( MSA), up 5.8%, Catamaran ( CTRX), up 3.0%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.2% and Smith & Nephew ( SNN), up 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. WellCare Health Plans ( WCG) is one of the companies pushing the Health Services industry lower today. As of noon trading, WellCare Health Plans is down $4.16 (-6.7%) to $58.06 on heavy volume. Thus far, 1.2 million shares of WellCare Health Plans exchanged hands as compared to its average daily volume of 472,400 shares. The stock has ranged in price between $57.70-$59.26 after having opened the day at $57.81 as compared to the previous trading day's close of $62.22.

WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs in the United States. WellCare Health Plans has a market cap of $2.8 billion and is part of the health care sector. Shares are down 11.6% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts that rate WellCare Health Plans a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates WellCare Health Plans as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full WellCare Health Plans Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, C.R. Bard ( BCR) is down $1.03 (-0.8%) to $135.62 on light volume. Thus far, 220,634 shares of C.R. Bard exchanged hands as compared to its average daily volume of 610,400 shares. The stock has ranged in price between $135.58-$137.37 after having opened the day at $136.50 as compared to the previous trading day's close of $136.65.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $10.4 billion and is part of the health care sector. Shares are up 2.0% year-to-date as of the close of trading on Tuesday. Currently there are 4 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full C.R. Bard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, Cigna ( CI) is down $0.65 (-0.8%) to $76.57 on heavy volume. Thus far, 1.2 million shares of Cigna exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $76.40-$77.63 after having opened the day at $77.39 as compared to the previous trading day's close of $77.22.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $21.2 billion and is part of the health care sector. Shares are down 11.7% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Humana ( HUM) is down $0.83 (-0.8%) to $96.44 on light volume. Thus far, 526,761 shares of Humana exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $96.36-$98.23 after having opened the day at $97.50 as compared to the previous trading day's close of $97.27.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $15.0 billion and is part of the health care sector. Shares are down 5.8% year-to-date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Humana a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, WellPoint ( WLP) is down $0.95 (-1.1%) to $84.73 on average volume. Thus far, 1.1 million shares of WellPoint exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $84.64-$86.32 after having opened the day at $85.66 as compared to the previous trading day's close of $85.68.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $25.0 billion and is part of the health care sector. Shares are down 7.3% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts that rate WellPoint a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Trump's Obamacare Payments Bombshell a Blow to Insurers and Patients

Trump's Obamacare Payments Bombshell a Blow to Insurers and Patients

Potential Takeover Candidate Molina Names New CEO

Potential Takeover Candidate Molina Names New CEO

Wall Street Weighs What's Next on Healthcare

Wall Street Weighs What's Next on Healthcare

Molina's Executive Shakeup Increases Possibility of Takeout

Molina's Executive Shakeup Increases Possibility of Takeout